SCHEMBL6367348

SCHEMBL6367348

CCOC(=O)c1cc(Cl)c(Oc2ccc(OC)cc2)c(Cl)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPBWR1 P48145 3/20 0.58
MCHR1 Q99705 2/20 0.58
TAS1R3 Q7RTX0 1/20 0.48
TAS1R1 Q7RTX1 1/20 0.48
TAS1R2 Q8TE23 1/20 0.48
PTGS2 P35354 1/20 0.47
MAPT P10636 4/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
CA14 Q9ULX7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL283181 0.85 CA1 (0.58) NPBWR1TAS1R3TAS1R1TAS1R2MAPT
SCHEMBL3243690 0.83 ALDH1A1 (0.57) TAS1R3TAS1R1TAS1R2MAPTMEN1
SCHEMBL6136040 0.83 NPBWR1 (0.49) NPBWR1MCHR1PTGS2MAPTSMN1; SMN2
SCHEMBL6368421 0.81 RORC (0.64) RAB9A
SCHEMBL282131 0.80 THRA (0.59) TAS1R3TAS1R1TAS1R2MAPTMEN1
SCHEMBL9359618 0.80 KDM4E (0.54) MAPTSMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL5837526 0.80 MAPT (0.59) NPBWR1MCHR1PTGS2MAPTSMN1; SMN2
SCHEMBL14879712 0.79 MEN1 (0.46) NPBWR1MCHR1PTGS2MAPTSMN1; SMN2
4-Methoxybenzoic Acid Ethyl Ester SCHEMBL203475 0.78 CA1 (0.66) MAPTSMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL3221253 0.78 POLB (0.48) NPBWR1MCHR1TAS1R3TAS1R1TAS1R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6960604-B2 Thyroid receptor ligands PFIZER INC. (US) 2005-11-01 US disclosed
US-20040110951-A1 Thyroid receptor ligands CHIANG YUAN-CHING P (US) 2004-06-10 US disclosed
US-6620830-B2 Certain thiazolidinedione, oxadiazolidinedione, and triazolone compounds which are thyroid receptor ligands PFIZER, INC. 2003-09-16 US disclosed
US-20010051645-A1 Thyroid receptor ligands CHIANG YUAN-CHING P (US) 2001-12-13 US disclosed
EP-1148054-A1 Thyroid receptor ligands Pfizer Products Inc. (US) 2001-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010051645-A1 Thyroid receptor ligands TSHR, THRB, THRA NPBWR1 599/4885MCHR1 180/4885TAS1R3 149/4885
US-20040110951-A1 Thyroid receptor ligands TSHR, THRB, THRA NPBWR1 599/4885MCHR1 180/4885TAS1R3 149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.